Bruton Tyrosine Kinase Inhibitor–Associated Pericardial Events by Agent and Generation
This cross-sectional study investigates rates of incident pericardial effusion or cardiac tamponade in patients receiving Bruton tyrosine kinase inhibitors.
Authors
- Kwan Lee (ORCID: https://orcid.org/0000-0003-2554-4170)
- Chadi Ayoub (ORCID: https://orcid.org/0000-0001-5877-7478)
- Amal Youssef (ORCID: https://orcid.org/0000-0002-7849-099X)
- Dina Hauptschein (ORCID: https://orcid.org/0009-0008-6618-6844)
- Reza Arsanjani (ORCID: https://orcid.org/0000-0001-7081-4286)
- Luis R. Scott (ORCID: https://orcid.org/0000-0002-1010-1062)
- Ramzi Ibrahim (ORCID: https://orcid.org/0000-0003-0124-9513)
- Talal Hilal (ORCID: https://orcid.org/0000-0001-8249-4128)
- Hemalatha Narayanasamy (ORCID: https://orcid.org/0000-0001-8976-5138)
- Balaji K. Tamarappoo (ORCID: https://orcid.org/0000-0002-8382-4421)
- Karam Mohannad Albdour (ORCID: https://orcid.org/0009-0006-9081-9790)
- Joerg Herrmann (ORCID: https://orcid.org/0000-0001-6675-4559)
- Luke Arnulfo Dreher (ORCID: https://orcid.org/0000-0002-5144-9292)
- Julia Zanco (ORCID: https://orcid.org/0009-0001-8716-5363)
- Vinicius De Sousa Barzon Serra (ORCID: https://orcid.org/0009-0007-9518-236X)
- J. Christopher Ray
- Amjed Al Abdel
Institutions
- Mayo Clinic (US)
- Mayo Clinic Hospital (US)
- Mayo Clinic in Florida (US)
Publication Details
- Journal
- JAMA Network Open
- Published
- 2026-11-09
- DOI
- https://doi.org/10.1001/jamanetworkopen.2026.42918
- Primary Topic
- Pericarditis and Cardiac Tamponade
- Type
- article
- Field-Weighted Citation Impact
- 0.00